Single-chain Fv multimers of the anti-neuraminidase antibody NC10: the residue at position 15 in the V(L) domain of the scFv-0 (V(L)-V(H)) molecule is primarily responsible for formation of a tetramer-trimer equilibrium.
暂无分享,去创建一个
Olan Dolezal | Mark Walter | A. Kortt | P. Hudson | O. Dolezal | M. Hattarki | R. De Gori | Larissa Doughty | Meghan Hattarki | Peter J Hudson | Ross De Gori | Larissa Doughty | Alexander A Kortt | M. Walter
[1] A. Plückthun,et al. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains. , 2001, Journal of molecular biology.
[2] R. Webster,et al. Recombinant antineuraminidase single chain antibody: Expression, characterization, and crystallization in complex with antigen , 1993, Proteins.
[3] E. Nice,et al. Determination of relative binding affinity of influenza virus N9 sialidases with the Fab fragment of monoclonal antibody NC41 using biosensor technology. , 1993, European journal of biochemistry.
[4] P. Colman,et al. Three-dimensional structures of single-chain Fv-neuraminidase complexes. , 1998, Journal of molecular biology.
[5] A. Kortt,et al. scFv multimers of the anti-neuraminidase antibody NC10: length of the linker between VH and VL domains dictates precisely the transition between diabodies and triabodies. , 1999, Protein engineering.
[6] R. Williams,et al. Crystal structure of a diabody, a bivalent antibody fragment. , 1994, Structure.
[7] J. Arends,et al. Absolute conservation of residue 6 of immunoglobulin heavy chain variable regions of class IIA is required for correct folding. , 1998, Protein engineering.
[8] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[9] E. Kabat,et al. Sequences of proteins of immunological interest , 1991 .
[10] Andrew M. Scott,et al. Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector , 2001, Cancer Immunology, Immunotherapy.
[11] A. Plückthun,et al. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment. , 1998, Biochemistry.
[12] A. Kortt,et al. Influence of mass transfer and surface ligand heterogeneity on quantitative BIAcoreTM binding data. Analysis of the interaction of NC10 Fab with an anti‐idiotype Fab′ , 1997, Journal of molecular recognition : JMR.
[13] L. Nieba,et al. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment. , 1997, Protein engineering.
[14] A. Kortt,et al. Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting. , 2001, Biomolecular engineering.
[15] R. Webster,et al. Recombinant anti-sialidase single-chain variable fragment antibody. Characterization, formation of dimer and higher-molecular-mass multimers and the solution of the crystal structure of the single-chain variable fragment/sialidase complex. , 1994, European journal of biochemistry.
[16] P. Iliades,et al. Orientation of antigen binding sites in dimeric and trimeric single chain Fv antibody fragments , 1998, FEBS letters.
[17] M. Little,et al. Di‐, tri‐ and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding , 1999, FEBS letters.
[18] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[19] A. Kortt,et al. ScFv multimers of the anti-neuraminidase antibody NC10: shortening of the linker in single-chain Fv fragment assembled in V(L) to V(H) orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers. , 2000, Protein engineering.
[20] E. Nice,et al. Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis. , 1999, Analytical biochemistry.
[21] W G Laver,et al. The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody. , 1994, Structure.
[22] P. Hudson,et al. Escherichia coli expression of a bifunctional Fab-peptide epitope reagent for the rapid diagnosis of HIV-1 and HIV-2. , 1995, Immunotechnology : an international journal of immunological engineering.
[23] P. V. von Hippel,et al. Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.
[24] E A Merritt,et al. Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.
[25] P. Kollman,et al. An all atom force field for simulations of proteins and nucleic acids , 1986, Journal of computational chemistry.
[26] T Prospero,et al. "Diabodies": small bivalent and bispecific antibody fragments. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Webster,et al. Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer. , 1997, Protein engineering.
[28] G. Adams,et al. Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu. , 1998, British Journal of Cancer.
[29] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .